Description

IPH 1201 is a follow-up compound with pharmacological properties very similar to the drug candidate IPH 1101, but much more potency. Whereas IPH 1101 is given intravenously, IPH 1201 could be given subcutaneously or orally.

The non clinical regulatory database, notably toxicology data, was generated for IPH 1201. The IND-file is thus ready for the entry of this candidate in clinics.